JANIE TROSCLAIR: Open Payments
NPI 1720444946 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,132 in 118 payments from 22 companies in 2025. Trend: 2023 $2,176 · 2024 $1,924 · 2025 $2,132
Food & beverage: $2,130Education: $2
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 17 | $284 |
| Novo Nordisk Inc | 14 | $236 |
| PFIZER INC. | 14 | $234 |
| ABBVIE INC. | 12 | $201 |
| AstraZeneca Pharmaceuticals LP | 10 | $185 |
| Axsome Therapeutics, Inc. | 8 | $173 |
| Lilly USA, LLC | 8 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $108 |
| Amgen Inc. | 4 | $74 |
Products named: FANAPT, Auvelity, Ozempic, FARXIGA, MOUNJARO, CAPLYTA, VRAYLAR, ELIQUIS.
Industry payments across LA — which companies pay providers there.
